TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Carmel Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/09 | 2022/09 | 2021/09 |
Turnover |
46,440
|
46,375
|
41,163 |
Financial expenses |
1
![]() |
1
|
6 |
Earnings before taxes |
53,553
|
46,404
|
42,435 |
EBITDA |
45,470
|
45,598
|
40,154 |
Total assets |
293,383
|
335,512
|
309,754 |
Current assets |
1,174
|
10,622
|
16,048 |
Current liabilities |
54,478
|
84,749
|
287 |
Equity capital |
238,905
|
250,763
|
268,436 |
- share capital |
5,753
|
6,039
|
6,463 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Solvency |
81.4%
|
74.7%
|
86.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
115.3%
|
100.1%
|
103.1% |
Return on assets (ROA) |
18.3%
|
13.8%
|
13.7% |
Current ratio |
2.2%
|
12.5%
|
5591.6% |
Return on equity (ROE) |
22.4%
|
18.5%
|
15.8% |
Change turnover |
2,264
|
7,913
|
-6,604 |
Change turnover % |
5%
|
21%
|
-14% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.